Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Preoperative MRI Critical in Identifying Spinal Cord Stimulation Patients

By HospiMedica International staff writers
Posted on 13 Nov 2023

Spinal cord stimulators (SCSs) are employed in managing chronic pain in the cervical, lumbar, and limb areas. More...

They function by placing electrodes in the epidural space near the spinal cord, delivering gentle electrical pulses to the nerves to alleviate pain. Despite their effectiveness, there is a small but significant risk of neurological harm associated with their implantation. To mitigate this risk, medical professionals often utilize preoperative magnetic resonance imaging (MRI) to identify the optimal spots for needle insertion and lead placement and to examine any spinal abnormalities a patient might have. After this imaging step, patients usually undergo a trial with the SCS before deciding on a permanent implant. However, these preoperative MRIs can lead to higher healthcare costs and the need for preauthorization.

Physicians at Pain Diagnostics and Interventional Care (PDIC, Pittsburgh, PA, USA) conducted a study to evaluate the impact of preoperative MRI on modifying treatment plans for cervical and thoracic SCS epidural lead placement. The study involved a retrospective review of patient cases spanning nearly a decade. The findings indicated that MRI indeed had a substantial impact in enough cases, justifying its ongoing use. Out of 343 patients who were evaluated for an SCS trial, 15 (4.4%) required an alteration in the procedure based on MRI results, while 10 patients (3%) were ruled out from proceeding with the SCS trial due to findings on the MRI. The results also showed that MRIs were more effective for patients suffering from cervical pain than those with thoracic or lumbar pain.

The study further revealed that older patients, particularly those aged 60 and above, were more prone to moderate-to-severe cervical and lumbar stenosis, necessitating changes in treatment. This was the first large-scale study examining the role of preprocedural MRIs in influencing the course of SCS percutaneous lead trials. The researchers concluded that, given the broad range of patient characteristics linked to a higher risk of stenosis, all patients should be considered for preprocedural MRI. This approach would help identify spinal pathologies that could potentially modify the progression of SCS percutaneous trials.

Related Links:
Pain Diagnostics and Interventional Care


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Exam Table
PF400
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.